Discuss challenges facing new biobanks and building sustainability in London

Single centre research facilities are evolving into research infrastructures as both the number of national biobanks and the efforts to build co-operative networks between them globally increases. Sharing, storing and use of biosamples can vary significantly in cost, social and scientific impact so there are efforts being made to associate value to existing biological resources.

The UK government have committed in the region of £250m into research and development, however more money is still required in order to acquire the latest technologies and services to keep biobanks maintained. Despite the financial strains, biobanks are becoming more commonplace. The UK Biobank in Stockport Manchester boasts nearly 500,000 samples and is setting the trend for how other banks across the world should organise themselves.

SMi’s Biobanking event taking place in London on the 11th & 12th July will aim to address important issues experienced by those who donate, manage and expend biobank samples. Key opinion leaders will provide up to date information on the important topics of today. With the proposed establishment of the Bio Resource Impact Factor and the continued harmonization, collaboration and standardization of biobanks world wide, these really are exciting times and this event will aim to capture this excitement and build on the accomplishments of 2011 by providing a platform for discussions and networking across a range of professions.

Why attend this event?
• Explore challenges facing new biobanks, strategies for cost recovery and sustainability
• Discover sample requirements of researchers in drug discovery
• Communicate with solution providers who provide technological innovations for managing biobanks
• Examine quality control and quality assurance practices
• Determine how to improve your infrastructure and better network with the biobanking community
• Discuss obstacles to people donating tissue for biomedical research

Network with our registered company representatives that include:
• Covington & Burling Llp
• Roche
• Elpro UK Ltd
• AstraZeneca
• Merck Research Laboratories
• Nottingham University Hospital NHS Trust
• National Cancer Institute
• UCL Medical School Royal Free Campus
• University College London
• Leo Pharma
• Chernobyl Tissue Bank
• Novartis Pharmaceuticals UK
• University of manchester school of translational medicine
• McGill University Department of Human Genetics
• Genetic Alliance
• Pasteur Hopital, University of Nice
• Labvantage Solutions
• Janssen-Cilag E M E A
• Kings College London
• NIHR Biomedical Research Centre
• Tissue Solutions
• University of Leicester
• Independent Consultancy
• Norwegian University Of Science And Technology
• Welcome Trust
• Karolinska Institute

For more information visit http://www.smi-online.co.uk/goto/bio-banking-event57.asp
Alternatively contact Fateja Begum on tel: +44 (0) 20 7827 6184 or Email: fbegum@smi-online.co.uk

The SMi Group is a world leader in business to business information. With nearly two decades in the business, thousands of senior executives from blue chip companies have already benefitted from SMi’s highly targeted conferences, workshops and publications. For more information visit www.smi-online.co.uk

SMi Group Ltd
2nd Floor South, Harling House
47-51 Great Suffolk Street,
London, SE1 0BS

This release was published on openPR.